Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-07-31): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Clearmind Medicine Inc.
Market Cap
$1.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.14M
Net Profit Margin
-8.46%
TTM Avg
-4.30%
3Y Avg
1.83%
5Y Avg
1.83%
Market Cap
$1.17M
Net Profit Margin
-38.08%
TTM Avg
-20.13%
3Y Avg
-101.84%
5Y Avg
-106.69%
Market Cap
$1.02M
Net Profit Margin
-11314.24%
TTM Avg
-197362.53%
3Y Avg
-98681.26%
5Y Avg
-78945.01%
Market Cap
$888387.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$885939.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$878396.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.36M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clearmind Medicine Inc. (CMND) | $1.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -8.46% | -4.30% | 1.83% | 1.83% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -38.08% | -20.13% | -101.84% | -106.69% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | 0.00% | 0.00% | -933.28% | -622.19% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
